Pharmaceuticals News and Research

RSS

Brain cancer awareness: 55-year-old cycles across USA

Anne Feeley, a 55-year-old mother and brain cancer survivor, will cycle across the country this spring to raise awareness and money for brain cancer research and support.

27 Feb 2010

Eli Lilly, Covance announce key milestones of their first-year partnership

Senior executives from Eli Lilly and Company and Covance Inc. announced Friday that the first year of their landmark alliance has been a win-win for both companies, enabling Lilly to expedite the flow of innovation within its pipeline in order to provide improved outcomes for individual patients.

27 Feb 2010

Canada's pharmaceutical products industry stands out strong during recession

Canada's pharmaceutical products industry stands out for its strong growth during the 2008-09 recession. This sets it apart from other industries covered in the Winter 2010 edition of The Conference Board of Canada's Canadian Industrial Profile Service - chemicals, plastic and rubber products, non-metallic mineral products, and computer and electronic products, which will take at least a couple of years to return to pre-recession production, revenue and profit levels.

27 Feb 2010

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

CHI-California Healthcare Institute, a non-profit public policy research organization, applauds the state Assembly’s proclamation of Feb. 28, as Rare Disease Day. This day helps bring awareness of the biomedical companies that are dedicated to researching and developing treatments for patients suffering from rare diseases.

27 Feb 2010

Shire receives marketing approval from FDA for VPRIV

Shire plc, the global specialty biopharmaceutical company, announced today that the U.S. Food and Drug Administration has granted marketing approval for VPRIV, a human cell line derived enzyme replacement therapy (ERT) for the long-term treatment of Type 1 Gaucher disease in pediatric and adult patients.

27 Feb 2010

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that Dr. Geoffrey I. Shapiro of Dana-Farber Cancer Institute, presented preclinical and clinical data on STA-9090, a potent second-generation Hsp90 inhibitor, at IASLC (International Association for the Study of Lung Cancer) 10th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting in Santa Monica, CA.

27 Feb 2010

TPG and CPPIB affiliates complete acquisition of IMS Health

IMS Health, the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the completion of its acquisition by entities created by certain affiliates of TPG Capital, L.P. and the CPP Investment Board.

27 Feb 2010

Medical innovation and research: A real boon for American patients to live longer, healthier

An article in the Suislaw News recently highlighted the fact that medical innovation and research are enabling many people to live longer, healthier and more productive lives.

26 Feb 2010

Thermo Fisher Scientific completes previously announced acquisition of Ahura Scientific

Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has completed its previously announced acquisition of Ahura Scientific, a leader in handheld Raman and FT-IR (Fourier-transform infrared) spectroscopy instruments that are used worldwide in the identification of chemicals for safety, security and pharmaceutical applications.

From Thermo Fisher Scientific Inc. 26 Feb 2010

Vion Pharmaceuticals' Onrigin SPA: FDA responds

VION PHARMACEUTICALS, INC. announced today that it had received a response from the U.S. Food and Drug Administration on a Special Protocol Assessment for its oncology therapeutic Onrigin™ (laromustine) Injection.

26 Feb 2010

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Arena Pharmaceuticals, Inc. announced today that the US Food and Drug Administration (FDA) has assigned a Prescription Drug User Fee Act (PDUFA) date of October 22, 2010, for the review of the lorcaserin New Drug Application (NDA). The acceptance of the lorcaserin NDA filing confirms that the application is sufficiently complete to permit a substantive review, and the PDUFA date is the goal date for the FDA to complete its review of the NDA.

26 Feb 2010

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Alexion Pharmaceuticals, Inc., has joined the National Organization for Rare Disorders (NORD) and the European Organization for Rare Diseases (EURORDIS) in supporting the goals of the third annual Rare Disease Day, February 28, 2010.

26 Feb 2010

Most internal medicine residency training program directors don't prefer pharmaceutical support

Most directors of internal medicine residency training programs would prefer not to accept pharmaceutical support for the residencies they oversee, but more than half report doing so, according to an article in the February 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

26 Feb 2010

Study: Relentless progression of new, expensive medical technology have created perfect storm of costs

Emerging Healthcare Solutions, Inc. reflected on a new Henry J. Kaiser Family Foundation www.kff.org study that reports that the relentless progression of new and expensive medical technology, combined with entitlement programs like Medicare and Medicaid, further compounded by an aging population, have created a "perfect storm" of costs that will consume well over half of all federal spending between now and the turn of the mid-century.

26 Feb 2010

Go4Europe conference to focus on current situation of pharmaceutical companies

The 8th Go4Europe conference, held on March 15, 2010 in the Tel Aviv Hilton, will include a panel focusing on "Innovation for Pharma and Access to Finance for Biotech."

26 Feb 2010

Teva Pharmaceutical announces clinical study results of Copaxone in RRMS patients

Teva Pharmaceutical Industries Ltd. today announced the publication of data from the 15-year clinical study with Copaxone® (glatiramer acetate injection), which is the longest prospective and continuous evaluation ever conducted in relapsing-remitting multiple sclerosis (RRMS) patients. The data were published in the February issue of the journal Multiple Sclerosis.

26 Feb 2010

UCB adopts Enterprise version of NextBio platform

NextBio, developer of an innovative software platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced a license agreement with global biopharmaceutical company UCB, for NextBio Enterprise. NextBio Enterprise offers life sciences organizations unique tools for knowledge discovery and collaboration, seamless integration of internal and external research data, and secure data access.

26 Feb 2010

Supelco launches Ascentis Express Peptide ES-C18 HPLC columns

Supelco, a division of Sigma-Aldrich®, announced today the launch of Ascentis Express Peptide ES-C18, a high-speed, high-performance liquid chromatography (HPLC) column based on a new 160 angstrom Fused-Core™ particle design. This column design exhibits very high column efficiency, providing a stable, reversed phase packing with a pore structure and pore size that is optimized for reversed-phase HPLC separations of peptides and polypeptides.

26 Feb 2010

KV Pharmaceutical makes agreement with U.S. Department of Justice to resolve investigation on ETHEX

KV Pharmaceutical Company today announced that it has reached an agreement, subject to court approval, with the United States Attorney for the Eastern District of Missouri and the Office of Consumer Litigation of the United States Department of Justice to resolve an investigation regarding certain activities of ETHEX Corporation, its generic pharmaceutical marketing and distribution subsidiary, which occurred in 2008.

26 Feb 2010

BioClinica Optimizer launched for clinical supply planning and management

BioClinica™, Inc., a global provider of clinical trial management services, today announced the launch of BioClinica Optimizer, a breakthrough for clinical supply planning and management that it believes has the potential to transform clinical trial supply forecasting and management.

From Clario 26 Feb 2010

Pharmaceuticals News and Research

Brain cancer awareness: 55-year-old cycles across USA

Eli Lilly, Covance announce key milestones of their first-year partnership

Canada's pharmaceutical products industry stands out strong during recession

CHI lauds California state Assembly's proclamation of Feb. 28, as Rare Disease Day

Shire receives marketing approval from FDA for VPRIV

Synta Pharmaceuticals presents preclinical and clinical data of Hsp90 inhibitor STA-9090

TPG and CPPIB affiliates complete acquisition of IMS Health

Medical innovation and research: A real boon for American patients to live longer, healthier

Thermo Fisher Scientific completes previously announced acquisition of Ahura Scientific

Vion Pharmaceuticals' Onrigin SPA: FDA responds

Arena Pharmaceuticals' lorcaserin NDA: FDA assigns PDUFA date

Rare Disease Day 2010: Alexion Pharmaceuticals joins NORD and EURORDIS to raise awareness

Most internal medicine residency training program directors don't prefer pharmaceutical support

Study: Relentless progression of new, expensive medical technology have created perfect storm of costs

Go4Europe conference to focus on current situation of pharmaceutical companies

Teva Pharmaceutical announces clinical study results of Copaxone in RRMS patients

UCB adopts Enterprise version of NextBio platform

Supelco launches Ascentis Express Peptide ES-C18 HPLC columns

KV Pharmaceutical makes agreement with U.S. Department of Justice to resolve investigation on ETHEX

BioClinica Optimizer launched for clinical supply planning and management

Event guide: World ADC San Diego eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Managing vibration in IVF laboratories

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence